TORONTO--(BUSINESS WIRE)--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that its products, including all five of the Heritage brands – Purefarma, Pura Vida, Premium 5, feelgood., and RAD - are available for purchase on the CannMart online platform. CannMart, a subsidiary of NamasteMD, is a Health Canada licensed desktop and mobile portal that gives cannabis consumers with medical cannabis authorization across Canada the flexibility to buy products quickly and conveniently delivered.
“We are thrilled to partner with CannMart as their online and mobile app will give medical cannabis consumers ease of access to 45 SKUs across all five Heritage brands – including RAD which has recently achieved #1 in category sales in a number of provinces,” said Clint Sharples, CEO of Heritage. “Our goal at Heritage is to offer high-quality, reasonably priced products that align with our customer’s needs. With this initial order, CannMart will carry the widest variety of Heritage brands available in one place throughout Canada, including more selection than any one province.”
Heritage’s products have been gaining recognition across Canada as leaders in the extract and extract derivatives categories, with some in-demand products selling out very quickly after becoming available for purchase.
Follow Heritage’s Purefarma, Pura Vida, Premium 5, and feelgood. brands on Instagram and Facebook for more information.
About Heritage Cannabis Holdings Corp.
Heritage is a leading cannabis products company operating two licensed manufacturing facilities in Canada and offering innovative products to both the medical and recreational legal cannabis markets in Canada and US. The company has an extensive portfolio of high quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood. and ArthroCBD.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“Clint Sharples”
Clint Sharples
CEO
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
